Literature DB >> 21350696

A case of histiocytoid variant eccrine sweat gland carcinoma of the orbit.

Young Min Kim1, Jeong Won Kim, Dong-Eun Oh.   

Abstract

A 79-year-old male presented with left ocular pain. Evisceration and silicone ball implantation were performed after a diagnosis of phthisis. He returned six weeks later because of left facial erythematous swelling, tenderness, mild fever, chills and cough. His condition was diagnosed as orbital cellulitis. Despite two weeks of empirical antibiotic therapy, the symptoms worsened. A subsequent orbital computed tomography scan revealed enhanced soft tissue infiltrations in his left orbit and eyelid. Biopsy showed a diffusely infiltrating tumor of signet ring cell cytology. A systemic evaluation revealed multiple bone metastases. Based on this evidence, the patient was diagnosed with a very rare case of histiocytoid variant eccrine sweat gland carcinoma with multiple bone metastases.

Entities:  

Keywords:  Eccrine sweat gland carcinoma; Histiocytoid variant; Signet ring cell

Mesh:

Year:  2011        PMID: 21350696      PMCID: PMC3039196          DOI: 10.3341/kjo.2011.25.1.54

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  8 in total

1.  Syringomatous carcinoma of the eyelid and orbit: a clinical and histopathological challenge.

Authors:  V P Hoppenreijs; T T Reuser; C M Mooy; R J de Keizer; M P Mourits
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 2.  Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.

Authors:  D J Langel; R P Yeatts; W L White
Journal:  Am J Dermatopathol       Date:  2001-10       Impact factor: 1.533

3.  Histiocytoid eccrine sweat gland carcinoma of the eyelid: report of a case.

Authors:  B Swinson; F Ryan; A W Barrett; W Jerjes; G Landon; E Calonje; N Kalavrezos
Journal:  Clin Exp Dermatol       Date:  2006-07-24       Impact factor: 3.470

Review 4.  Signet ring cell carcinoma of the eccrine sweat glands in the eyelid.

Authors:  G Wollensak; H Witschel; N Böhm
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

5.  Histiocytoid variant of eccrine sweat gland carcinoma of the eyelid and orbit: report of five cases.

Authors:  Theresa R Kramer; Hans E Grossniklaus; Ian W McLean; James Orcutt; W Richard Green; Nicholas T Iliff; Francesc Tressera
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

6.  Eccrine duct carcinoma of the eyelid mimicking meibomian carcinoma: clinicopathological study of a case.

Authors:  Subramanian Krishnakumar; E Ravindra Mohan; Kalpana Babu; Dipankar Das; Jyotirmay Biswas
Journal:  Surv Ophthalmol       Date:  2003 Jul-Aug       Impact factor: 6.048

7.  Signet ring cell carcinoma of the eyelid - the monocle tumour.

Authors:  Anouck Leuba Mortensen; Steffen Heegaard; Ole Clemmensen; Jan Ulrik Prause
Journal:  APMIS       Date:  2008-04       Impact factor: 3.205

8.  Primary infiltrating signet ring carcinoma of the eyelids.

Authors:  F A Jakobiec; P Austin; T Iwamoto; S L Trokel; M D Marquardt; W Harrison
Journal:  Ophthalmology       Date:  1983-03       Impact factor: 12.079

  8 in total
  3 in total

1.  Sclerosing Signet Ring Cell Carcinoma of the Lacrimal Gland: A Potentially New Primary Entity.

Authors:  Frederick A Jakobiec; Edith R Reshef; Lina Ma; Martin K Selig; Daniel R Lefebvre; Anna M Stagner
Journal:  Ocul Oncol Pathol       Date:  2020-02-07

2.  Diagnostic and treatment challenges of a case of primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.

Authors:  Mathew M Palakkamanil; Muhammad N Mahmood; Audrey Chan
Journal:  BMC Ophthalmol       Date:  2020-10-14       Impact factor: 2.209

3.  Bilateral primary histiocytoid eccrine sweat gland carcinoma of eyelids.

Authors:  Malgorzata Seredyka-Burduk; Pawel Krzysztof Burduk; Magdalena Bodnar; Grazyna Malukiewicz; Andrzej Kopczynski
Journal:  Braz J Otorhinolaryngol       Date:  2016-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.